These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 38664575)

  • 1. Targeting immune cell recruitment in atherosclerosis.
    Döring Y; van der Vorst EPC; Weber C
    Nat Rev Cardiol; 2024 Nov; 21(11):824-840. PubMed ID: 38664575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Cell Recruitment in Cardiovascular Disease.
    Marchini T; Mitre LS; Wolf D
    Front Cell Dev Biol; 2021; 9():635527. PubMed ID: 33681219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis - A matter of unresolved inflammation.
    Viola J; Soehnlein O
    Semin Immunol; 2015 May; 27(3):184-93. PubMed ID: 25865626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue.
    Surmi BK; Hasty AH
    Vascul Pharmacol; 2010; 52(1-2):27-36. PubMed ID: 20026286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune and inflammatory mechanisms of atherosclerosis (*).
    Galkina E; Ley K
    Annu Rev Immunol; 2009; 27():165-97. PubMed ID: 19302038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall.
    Huo Y; Xia L
    Trends Cardiovasc Med; 2009 May; 19(4):140-5. PubMed ID: 19818951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis as an inflammatory disease.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
    Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells as effectors in atherosclerosis.
    Bot I; Shi GP; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):265-71. PubMed ID: 25104798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation during the life cycle of the atherosclerotic plaque.
    Libby P
    Cardiovasc Res; 2021 Nov; 117(13):2525-2536. PubMed ID: 34550337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines in the vascular inflammatory response of atherosclerosis.
    Zernecke A; Weber C
    Cardiovasc Res; 2010 May; 86(2):192-201. PubMed ID: 20007309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models.
    Jones DP; True HD; Patel J
    Mediators Inflamm; 2017; 2017():9746169. PubMed ID: 28465628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets in atherosclerosis.
    Lievens D; von Hundelshausen P
    Thromb Haemost; 2011 Nov; 106(5):827-38. PubMed ID: 22012554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of atherosclerosis.
    Garrido-Urbani S; Meguenani M; Montecucco F; Imhof BA
    Semin Immunopathol; 2014 Jan; 36(1):73-91. PubMed ID: 24212253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ins and Outs of Myeloid Cells in Atherosclerosis.
    Schumski A; Winter C; Döring Y; Soehnlein O
    J Innate Immun; 2018; 10(5-6):479-486. PubMed ID: 29669334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
    Fredman G; MacNamara KC
    Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease.
    Fredman G; Serhan CN
    Nat Rev Cardiol; 2024 Nov; 21(11):808-823. PubMed ID: 38216693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.